Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Int J Hyperthermia ; 21(1): 29-44, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15764349

ABSTRACT

Both clinical and experimental investigations have shown that maternal hyperthermia during critical stages of embryo development can induce malformations in the offspring. Studies of the effect of heat stress on the placental functions are limited to the ewes, but that on microscopic structure is unknown. In the present study, rats were exposed to 41 or 42 degrees C for 1 h on gestation day (GD) 9. The controls were sham treated. Fetuses and placentas were collected on GD 20. Intrauterine growth retardation (IUGR) and several craniofacial malformations were observed in the fetuses of the heat-treated group. The placentas of the 42 degrees C group were significantly lighter in weight than those of the control. Light microscopy (LM) revealed thickening, hyalinization and occasional lymphocytic infiltration of the decidua basalis. Giant cells were prominent and glycogen cells had degenerated, leaving behind large cysts in the basal (spongy) zone. Best's carmine stain with or without diastase indicated the reduction in number and degeneration of glycogen cells and cyst formation. The labyrinthine zone was relatively thin in comparison to that of the controls. Perivascular fibrosis and paucity of vascularization were other features of the placentas of the hyperthermia group. Electron microscopy (EM) revealed lipid droplet accumulation in the trophoblast, the presence of myelin bodies and an increased production of collagen in the basal zone. Perivascular fibrosis appeared to have contributed to placental barrier thickening. EM also revealed accumulation of glycogen and lipid droplets in the trophoblasts and fibrin secretion into the extracellular space of the labyrinthine zone. These data suggest that placental pathology possibly contributes to fetal growth retardation in maternally heat-stressed rat fetuses.


Subject(s)
Fetal Growth Retardation/pathology , Fever/pathology , Placenta/pathology , Animals , Craniofacial Abnormalities/etiology , Craniofacial Abnormalities/pathology , Environmental Exposure , Female , Fetal Growth Retardation/etiology , Fetus/pathology , Fever/complications , Fibrosis , Microscopy, Electron , Placenta/ultrastructure , Pregnancy , Rats , Rats, Wistar , Stress, Physiological/pathology
2.
Mol Cell Biochem ; 261(1-2): 123-35, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15362495

ABSTRACT

The mechanism of diabetic embryopathy is not known. Excessive reactive oxygen species (ROS) produced in diabetes may be causally related to foetal anomalies. The objective of this study was to determine whether supplementation with the antioxidant lipoic acid (LA) could prevent maternal diabetes-related foetal malformations and intrauterine growth retardation (IUGR) in rats. Pregnant rats were non-treated (Group I) or made diabetic on gestation day (GD) 2 by injecting streptozotocin (Group II). Group III was injected with 20 mg kg(-1) of LA daily starting on GD 6 and continued through GD 19. Group IV was administered only Tris buffer on the corresponding days. Group V was a set of STZ-treated animals, which were supplemented with a daily dose of 20 mg kg(-1) of LA from GD 6 through GD 19. All fetuses were collected on GD 20. Lipoic acid did not affect the blood sugar levels of diabetic animals significantly but improved their body weight gain and reduced food and water consumption. Diabetic group had a high incidence of embryonic resorption, IUGR, craniofacial malformations, supernumerary ribs and skeletal hypoplasia. Lipoic acid significantly reduced these abnormalities. These data support the hypothesis that ROS are causally related to fetal maldevelopment and IUGR associated with maternal diabetes in the rat. They also highlight the possible role of antioxidants in the normal processes of embryo survival, growth and development.


Subject(s)
Antioxidants/therapeutic use , Fetal Growth Retardation/prevention & control , Pregnancy in Diabetics/complications , Thioctic Acid/therapeutic use , Animals , Blood Glucose/drug effects , Blood Glucose/metabolism , Body Weight/drug effects , Bone Development/drug effects , Diabetes Mellitus, Experimental/chemically induced , Diabetes Mellitus, Experimental/embryology , Diabetes Mellitus, Experimental/metabolism , Drinking/drug effects , Eating/drug effects , Embryonic Development/drug effects , Female , Fetal Growth Retardation/etiology , Fetal Growth Retardation/metabolism , Fetus/abnormalities , Pregnancy , Pregnancy in Diabetics/chemically induced , Pregnancy in Diabetics/embryology , Rats , Skull/abnormalities
SELECTION OF CITATIONS
SEARCH DETAIL
...